Kiniksa Pharmaceuticals reports third-quarter EPS
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Suncorp Expects FY27 Gross Premium Growth of 3% After Contract Loss
Suncorp cited the loss of a $125 million commercial contract and continued weakness in the New Zealand dollar.
M impact | EARNINGS | Oct 29, 2026, 02:35 PM UTC
Insmed shares rise after revenue outlook raised
Insmed shares posted their biggest intraday gain in more than two months after the company raised its revenue outlook.
M impact | EARNINGS | Oct 29, 2026, 02:35 PM UTC
Lilly Shares Hit Record High After Raising Forecasts
Lilly shares reached record highs after the company raised forecasts tied to its obesity medicines.
M impact | EARNINGS | Oct 29, 2026, 02:34 PM UTC
Bausch Health Shares Surge 21% on Third-Quarter Beat, Higher Guidance
Bausch Health shares rose 21% after third-quarter profit topped expectations, supported by sales growth for its flagship gastrointestinal drug. The company upgraded its full-year g
M impact | EARNINGS | Oct 29, 2026, 02:33 PM UTC
Basler 9M Sales Rise on Semiconductor and Data-Center Demand; 2026 Outlook Lifted
M impact | EARNINGS | Oct 29, 2026, 02:28 PM UTC
Metsa Board Reports Q3 EBITDA of €25.6 Million
M impact | EARNINGS | Oct 29, 2026, 02:26 PM UTC